术中神经监测避免双侧喉返神经损伤的成本效果
该研究构建 Markov 链模型,评估全甲状腺切除术中使用术中神经监测(IONM)避免双侧喉返神经(RLN)损伤的成本效果。基础病例为 40 岁女性左侧 4·1 cm 甲状腺乳头状癌患者,随访 20 年,支付意愿阈值设为每质量调整生命年(QALY)€38 000(US $50 000)。结果显示使用 IONM 的增量成本效果比为每 QALY €35 285·26(US $46 427·97),低于支付意愿阈值,结论为 IONM 具有成本效果。
要点
- IONM 增量成本效果比为每 QALY €35 285·26,低于 €38 000 的支付意愿阈值。
- Monte Carlo 模拟显示 IONM 在 85·8% 人群中为首选策略。
- 研究针对计划行双侧甲状腺手术、术中监测信号丢失的 RLN 损伤情景。
核心结论
- 在双侧甲状腺手术患者中,使用 IONM 具有成本效果。
- IONM 增量成本效果比低于设定的支付意愿阈值,被视为首选且具成本效果的管理方案。
研究设计与样本
- 构建基于 IONM 使用的 Markov 链模型。
- 基础病例为 40 岁女性,左侧 4·1 cm 甲状腺乳头状癌,计划双侧甲状腺切除术中发生 RLN 损伤伴监测信号丢失。
- 假设若使用 IONM 可检测到 RLN 损伤并改行甲状腺叶切除术以避免对侧 RLN 损伤风险。
- 成本以美元换算为欧元,概率与效用值来自文献和政府资源。
- 随访时间设为 20 年,支付意愿为每 QALY €38 000(US $50 000)。
主要发现
- 第 20 年末,不使用 IONM 策略累计 €163 995·40(US $215 783·43),效果为 14·15 QALYs。
- 使用 IONM 策略累计 €170 283·68(US $224 057·48),效果为 14·33 QALYs。
- 使用与不使用 IONM 相比的增量成本效果比为每 QALY €35 285·26(US $46 427·97)。
- Monte Carlo 模拟在假设的 10 000 例患者样本中考虑主要研究因素变异,IONM 在 85·8% 人群中为首选策略。
关键数值与推荐
- 支付意愿阈值:每 QALY €38 000(US $50 000)。
- 增量成本效果比:每 QALY €35 285·26(US $46 427·97)。
- 随访时间:20 年。
- Monte Carlo 模拟样本量:10 000 例患者。
- IONM 为首选策略的人群比例:85·8%。
临床怎么用
- 对于计划行双侧甲状腺手术的患者,可考虑使用 IONM 以降低双侧 RLN 损伤风险并具成本效果。
- 术中监测信号丢失时,可结合 IONM 信息调整手术范围(如改行甲状腺叶切除术)以避免对侧 RLN 损伤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intraoperative nerve monitoring (IONM) provides dynamic neural information and is recommended for high-risk thyroid surgery. In this analysis, the cost-effectiveness of IONM in preventing bilateral recurrent laryngeal nerve (RLN) injury was investigated. METHODS: A Markov chain model was constructed based on IONM use. The base-case patient was defined as a 40-year-old woman presenting with a 4·1-cm left-sided papillary thyroid cancer who developed RLN injury with loss of monitoring signal during planned bilateral thyroidectomy. It was hypothesized that, if the surgeon had used IONM, the RLN injury would have been detected and the operation would have been concluded as a thyroid lobectomy to avoid the risk of contralateral RLN injury. Cost in US dollars was converted to euros; probabilities and utility scores were identified from the literature and government resources. Length of follow-up was set as 20 years, and willingness-to-pay (WTP) as €38 000 (US $50 000) per quality-adjusted life-year (QALY). RESULTS: At the end of year 20, the not using IONM strategy accrued €163 995·40 (US $215 783·43) and an effectiveness of 14·15 QALYs, whereas use of the IONM strategy accrued €170 283·68 (US $224 057·48) and an effectiveness of 14·33 QALYs. The incremental cost-effectiveness ratio, comparing use versus no use of IONM, was €35 285·26 (US $46 427·97) per QALY, which is below the proposed WTP, indicating that IONM is the preferred and cost-effective management plan. A Monte Carlo simulation test that considered variability of the main study factors in a hypothetical sample of 10 000 patients showed IONM to be the preferred strategy in 85·8 per cent of the population. CONCLUSION: Use of IONM is cost-effective in patients undergoing bilateral thyroid surgery.
引用
- Al-Qurayshi Z, Kandil E, Randolph GW, et al. Cost-effectiveness of intraoperative nerve monitoring in avoidance of bilateral recurrent laryngeal nerve injury in patients undergoing total thyroidectomy. Br J Surg. 2017. PMID: 28707698. doi:10.1002/bjs.10582
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。